Gaston de Serres
Dr Gaston De Serres obtained his MD and his PhD in Epidemiology at Laval University where he is currently full Professor of Epidemiology. Dr. De Serres is also currently Medical Epidemiologist at the Institut National de santé publique du Québec (INSPQ) where he is the Medical Chief of the Immunization Scientific Unit.
He is the lead expert in charge of the influenza vaccination program and of vaccine safety issues. He is a member of the Quebec Immunization Committee since 1999 and was a member of the National Advisory Committee on Immunization (NACI) between 1997 and 2004. He is a member of the Canadian National Working Group on measles and rubella elimination. He is also a member of the Quebec Vaccine Adverse Event Surveillance Group (ESPRI) since 1996. He has published more than 220 peer-reviewed articles including many vaccine safety studies. He conducted many studies on the oculo-respiratory syndrome, an adverse event associated with the influenza vaccine that was first identified in Canada in 2000. He was the team leader of the vaccine safety theme of the Public Health Agency of Canada-CIHR Influenza research network (PCIRN) and organized the studies that ultimately lead to dropping the contraindication to vaccinate egg-allergic patients against influenza.
He has set-up a network of Special immunization clinics throughout the country where patients who suffered adverse events following immunization and those with potential contraindications could be evaluated and vaccinated.